Betamethasone dipropionate: Potent topical glucocorticoid in dermatology
Betamethasone dipropionate is a synthetic halogenated glucocorticoid in the dipropionate salt form, used in dermatology as a potent to very potent topical steroid (Class 3 to 4 according to European classification). Known brand names are Diprosone, Diprosalic (with salicylic acid), Daivobet (with calcipotriol for psoriasis) and numerous generics.
Compared to the betamethasone valerate salt form, betamethasone dipropionate is significantly more potent, with approximately ten-fold stronger anti-inflammatory activity per unit mass. This high potency makes it suitable for severe therapy-resistant inflammatory skin diseases, but requires careful limitation of use due to local and systemic adverse effects with long-term application.
Mechanism of action
Betamethasone dipropionate binds to the intracellular glucocorticoid receptor in skin cells. The activated complex migrates to the cell nucleus and influences the transcription of numerous genes. The result is strong inhibition of pro-inflammatory mediators such as interleukins, TNF alpha, prostaglandins and leukotrienes, as well as reduction of immune cell recruitment to inflamed tissue.
The antiproliferative effect on keratinocytes explains efficacy in psoriasis and other hyperproliferative diseases. The vasoconstrictive effect reduces erythema and edema. However, the immunosuppressive effect can also lead to increased susceptibility to skin infections.
Pharmacokinetically, betamethasone dipropionate is absorbed approximately 5 to 10 percent when applied topically to intact skin. With damaged skin, occlusive dressing, application to the face or in intertriginous areas, and in infants, absorption is significantly higher, with risk of systemic glucocorticoid effects.
Indications
- Psoriasis vulgaris: Plaque psoriasis, especially in combination with calcipotriol (Daivobet)
- Lichen ruber planus
- Atopic eczema (atopic dermatitis): In acute flares of moderate to severe form, short-term application
- Discoid lupus erythematosus
- Pityriasis rubra pilaris
- Hyperkeratotic eczematous skin diseases
- Granuloma annulare
Dosage and application
Standard dose: 0.05 percent cream, ointment, gel or solution applied thinly to the affected skin area once or twice daily. Duration of application generally not longer than 2 to 4 weeks, followed by treatment break or switch to weaker steroid (step-down therapy).
Maintenance therapy for psoriasis and atopic eczema: Proactive application 2 times per week to affected areas can reduce relapses (Daivobet, Cibinqo concept). This strategy is recommended in some guidelines.
Application areas: Not on the face, mucous membranes, genital or anal area, in intertriginous spaces (armpits, groin) due to increased systemic absorption and skin atrophy risk.
Maximum amount: For adults, maximum 50 g ointment or cream per week, for children significantly less based on body weight and treated area.
Adverse effects
Frequent (local): Skin atrophy, telangiectasias (visibly dilated skin vessels), striae distensae (stretch marks), hypopigmentation or hyperpigmentation, perioral dermatitis, steroid acne, hypertrichosis, tachyphylaxis (loss of efficacy with continuous use).
Occasional: Allergic contact eczema, burning, pruritus, secondary skin infections with bacteria, fungi or viruses.
Severe with systemic absorption: Cushing syndrome (moon facies, buffalo hump, striae, central obesity), suppression of the hypothalamic-pituitary-adrenal axis, hyperglycemia, hypertension, growth retardation in children, intracranial hypertension. These systemic effects are not expected with correct application to small skin areas over short periods, but occur with large-area and long-term application or under occlusion.
Important: When used on the face or in intertriginous areas, there is increased risk of skin atrophy and perioral dermatitis. In infants and small children, betamethasone dipropionate should be avoided if possible.
Drug interactions
- Other topical glucocorticoids: Do not apply simultaneously to the same area, additive effects and risks
- Systemic glucocorticoids: Additive systemic effects with large-area or long-term topical application
- Topical calcineurin inhibitors (tacrolimus, pimecrolimus): Steroid-sparing alternative therapy, often alternating application
- Calcipotriol: Combined in Daivobet, additive antipsoriatic effect
- Salicylic acid: Combined in Diprosalic, keratolytic effect enhances absorption
Special precautions
Pregnancy and breast-feeding: Topical application of small amounts over short periods is considered acceptable. With large-area or long-term application, systemic absorption must be considered. During breast-feeding, do not apply to breast or nipples.
Step-down therapy: After achieving symptom control, therapy should be gradually reduced, with switch to a weaker steroid or steroid-sparing alternative such as tacrolimus or pimecrolimus.
Fingertip unit (FTU): The fingertip unit (FTU) dosing unit (amount of ointment from the last finger joint to the tip, approximately 0.5 g) is used to standardize the application amount. One FTU is sufficient for a palm-sized skin area.
Tachyphylaxis phenomenon: With continuous use, efficacy often decreases after weeks. Treatment breaks, change of substance or steroid-sparing alternatives can help.
In case of skin infection: Glucocorticoids alone can worsen bacterial, viral or fungal skin infections. If secondary infection is suspected (pus, erysipelas, tinea, herpes), anti-infective therapy should be added or initiated before the steroid.
You might also be interested in
- Betamethasone valerate, weaker salt form
- Clobetasol, very potent topical steroid (Class 4)
- Hydrocortisone, mild topical steroid (Class 1)
- Calcipotriol, vitamin D analogue in combination for psoriasis
- Tacrolimus, calcineurin inhibitor as steroid-sparing alternative
Frequently asked questions
How potent is betamethasone dipropionate compared to other steroids?
Betamethasone dipropionate is a potent to very potent steroid (Class 3 to 4 according to European classification), approximately ten times more potent than betamethasone valerate (Class 2 to 3). Weaker steroids such as hydrocortisone are Class 1, while clobetasol is very potent Class 4. Selection depends on skin disease, location and patient age.
Why not use on the face?
Facial skin is particularly thin and sensitive. Potent steroids can cause skin atrophy, telangiectasias, perioral dermatitis and rebound erythema. On the face, usually only mild steroids (hydrocortisone Class 1, at most temporarily Class 2) or calcineurin inhibitors such as tacrolimus are used.
How long may I use betamethasone dipropionate?
Generally not longer than 2 to 4 weeks continuously. For chronic skin diseases such as psoriasis, intermittent proactive application (e.g. 2 times per week) may be appropriate as maintenance therapy. Longer application increases the risk of local skin changes and systemic effects.
What to do if efficacy is lost after a few weeks?
Tachyphylaxis is a known phenomenon with topical steroids. Options include short treatment breaks, switching to a different substance, addition of a steroid-sparing alternative such as tacrolimus or calcipotriol, or in refractory cases escalation to systemic therapy (methotrexate, biologics).
Sources
- Gelbe Liste, Betamethasone dipropionate active ingredient profile
- AWMF S3 guideline psoriasis and atopic eczema
- BfArM, Federal Institute for Drugs and Medical Devices
- EMA Product information betamethasone preparations
Legal notices and disclaimer
The information provided on this page is for general informational purposes only and does not constitute medical advice, diagnosis or treatment recommendation. It does not replace the advice of a licensed physician or pharmacist. Medicines should always be taken only on medical prescription or with pharmaceutical dispensing. All information is based on product information published at the time of preparation and recognized scientific sources; the current product information of the manufacturer is authoritative. Sanoliste assumes no liability for completeness, timeliness or accuracy of the information presented. In case of medical emergency, call emergency number 112.